Satsuma Pharmaceuticals,a clinical-stage biopharmaceutical company has appointed Mutya Harsch (pictured) to its board of directors, effective immediately. Harsch brings over 20 years of legal, corporate governance, corporate transaction, and operating experience to Satsuma. She currently
InhousecommunityUS.com
is the international magazine, in English, that covers legal and inhouse affairs in the United States, through experiences beyond Italy’s borders to reach overseas destinations and all over the world.
For more information, visit the Group’s website www.lcpublishinggroup.com
